Unresectable, locally advanced Cholangiocarcinomas
Drug | Drug Name | Drug Description |
---|---|---|
DB11886 | Infigratinib | An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. |
DB15102 | Pemigatinib | A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. |
Drug | Drug Name | Phase | Status | Count |
---|